Anixa Biosciences, Inc. (ANIX) Balance Sheet
ANIX balance sheet, FY2025
October 31, 2025 · U.S. dollars$16.1M assets = $2.1M liabilities + $13.9M equity
Both columns are drawn to the same scale: what ANIX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ANIX financial health
Descriptive bands, not a rating. Fiscal FY2025.
ANIX balance sheet trends, FY2016–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $5.6MFY2016 | $16.1MFY2025 | +12.4%/yr | |
| Total liabilities | $4.6MFY2016 | $2.1MFY2025 | −8.3%/yr | |
| Shareholders’ equity | $987,475FY2016 | $15.2MFY2025 | +35.5%/yr | |
| Cash & short-term investments | $3.2MFY2016 | $15.2MFY2025 | +18.7%/yr | |
| Total debt | $4.2MFY2016 | $204,000FY2025 | −28.5%/yr | |
| Net cash (debt) | −$933,553FY2016 | $15.0MFY2025 | +$15.9M | |
| Working capital | $2.9MFY2016 | $13.9MFY2025 | +$11.0M | |
| Book value per share | $0.11FY2016 | $0.47FY2025 | +17.1%/yr | |
| Current ratio | 7.25FY2016 | 8.08FY2025 | +0.82 | |
| Debt / equity | 4.22FY2016 | 0.01FY2025 | −4.21 | |
| Shares outstanding | 8.7MFY2016 | 32.5MFY2025 | +15.7%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ANIX assets
ANIX liabilities and equity
ANIX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ANIX balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $15.2M | $19.9M | $23.8M | $29.7M | $35.7M | $9.1M | $5.8M | $5.1M | $6.8M | $3.2M |
| Cash & equivalents | $1.2M | $1.3M | $915,000 | $12.4M | $29.1M | $6.4M | $3.5M | $3.1M | $3.3M | $2.5M |
| Short-term investments | $13.9M | $18.7M | $22.9M | $17.3M | $6.6M | $2.6M | $2.4M | $2.0M | $3.5M | $750,000 |
| Receivables | $0 | $173,000 | $270,000 | $46,000 | $0 | $2,231 | $66,527 | $306,991 | $0 | $0 |
| Inventory | $0 | $0 | $0 | −$46,000 | $0 | −$2.6M | −$2.4M | $1 | $0 | $0 |
| Other current assets | $713,000 | $1.3M | $1.2M | $513,000 | $275,556 | $2.9M | $2.5M | $175,490 | $174,566 | $162,069 |
| Total current assets | $15.9M | $21.4M | $25.4M | $30.2M | $36.0M | $9.4M | $6.1M | $5.5M | $7.0M | $3.4M |
| Property, plant & equipment (net) | $193,000 | $229,000 | $166,000 | $212,000 | $253,955 | $54,340 | $200,569 | $72,670 | $52,701 | $156,644 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $837,500 | $1.7M | $2.1M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $30,000 | $0 | $0 | $0 | $0 |
| Total assets | $16.1M | $21.6M | $25.5M | $30.4M | $36.3M | $9.5M | $6.3M | $6.4M | $8.8M | $5.6M |
| Liabilities | ||||||||||
| Accounts payable | $165,000 | $525,000 | $206,000 | $265,000 | $136,000 | $232,368 | $585,817 | $582,012 | $480,324 | $373,224 |
| Short-term debt | $41,000 | $29,000 | $52,000 | $46,000 | $39,000 | $55,198 | — | — | — | — |
| Total current liabilities | $2.0M | $2.5M | $2.0M | $2.0M | $1.3M | $1.2M | $1.5M | $1.3M | $889,493 | $468,756 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $204,000 | $232,000 | $175,000 | $221,000 | $259,479 | $55,198 | — | — | — | — |
| Other long-term liabilities | $163,000 | $203,000 | $123,000 | $175,000 | $220,082 | $287,566 | $585,817 | $582,012 | $480,324 | $4.2M |
| Total liabilities | $2.1M | $2.7M | $2.2M | $2.2M | $1.5M | $1.2M | $1.5M | $1.3M | $889,493 | $4.6M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $330,000 | $322,000 | $311,000 | $309,000 | $300,509 | $242,486 | $203,317 | $175.6M | $166,028 | $87,524 |
| Retained earnings (deficit) | −$251.7M | −$240.8M | −$228.2M | −$218.4M | −$204.8M | −$191.8M | −$181.8M | −$170.2M | −$156.2M | −$151.2M |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 | — |
| Accumulated other comprehensive income | — | — | — | — | — | — | −$95,015 | −$53,799 | −$35,725 | −$101,524 |
| Minority interest | −$1.2M | −$1.1M | −$966,000 | −$847,000 | — | −$496,983 | −$422,975 | −$251,377 | −$31,720 | — |
| Total shareholders' equity | $15.2M | $20.0M | $24.3M | $29.0M | $35.4M | $8.8M | $5.2M | $5.4M | $7.9M | $987,475 |
| Key figures | ||||||||||
| Total debt | $204,000 | $232,000 | $175,000 | $221,000 | $259,000 | $55,198 | — | — | — | $4.2M |
| Net cash (debt) | $15.0M | $19.7M | $23.7M | $29.5M | $35.5M | $9.0M | — | — | — | −$933,553 |
| Working capital | $13.9M | $18.9M | $23.3M | $28.2M | $34.7M | $8.2M | $4.6M | $4.3M | $6.1M | $2.9M |
| Tangible book value | $15.2M | $20.0M | $24.3M | $29.0M | $35.4M | $8.8M | $5.2M | $4.6M | $6.2M | −$1.1M |
| Book value per share | $0.47 | $0.63 | $0.79 | $0.96 | $1.24 | $0.39 | $0.26 | $0.31 | $0.65 | $0.11 |
| Shares outstanding | 32.5M | 31.9M | 31.0M | 30.4M | 28.6M | 22.2M | 19.8M | 17.6M | 12.2M | 8.7M |
| Current ratio | 8.08 | 8.54 | 12.50 | 14.83 | 28.35 | 7.88 | 4.11 | 4.38 | 7.89 | 7.25 |
| Quick ratio | 7.71 | 8.04 | 11.89 | 14.60 | 28.13 | 7.62 | 3.99 | 4.24 | 7.69 | 6.91 |
| Debt / equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | — | — | — | 4.22 |
| Equity / assets | 94.3% | 92.6% | 95.4% | 95.5% | 97.7% | 92.7% | 83.2% | 84.3% | 89.9% | 17.5% |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 | Apr '24 | Jan '24 | Oct '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $13.9M | $13.7M | $14.2M | $15.2M | $16.0M | $15.6M | $17.3M | $19.9M | $20.7M | $23.2M | $23.8M | $23.8M |
| Cash & equivalents | $1.4M | $1.5M | $1.5M | $1.2M | $1.5M | $1.9M | $1.1M | $1.3M | $1.2M | $995,000 | $998,000 | $915,000 |
| Short-term investments | $12.5M | $12.2M | $12.7M | $13.9M | $14.5M | $13.7M | $16.2M | $18.7M | $19.5M | $22.2M | $22.8M | $22.9M |
| Receivables | $0 | $56,000 | $0 | $0 | $0 | $0 | $0 | $173,000 | $410,000 | $218,000 | $391,000 | $270,000 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.0M | $950,000 | $848,000 | $713,000 | $1.4M | $1.2M | $1.4M | $1.3M | $1.5M | $757,000 | $1.0M | $1.2M |
| Total current assets | $14.9M | $14.7M | $15.1M | $15.9M | $17.4M | $16.8M | $18.7M | $21.4M | $22.7M | $24.2M | $25.2M | $25.4M |
| Property, plant & equipment (net) | $163,000 | $173,000 | $183,000 | $193,000 | $202,000 | $211,000 | $220,000 | $229,000 | $238,000 | $141,000 | $153,000 | $166,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $15.1M | $14.9M | $15.2M | $16.1M | $17.7M | $17.0M | $18.9M | $21.6M | $22.9M | $24.4M | $25.4M | $25.5M |
| Liabilities | ||||||||||||
| Accounts payable | $282,000 | $252,000 | $148,000 | $165,000 | $276,000 | $284,000 | $600,000 | $525,000 | $302,000 | $215,000 | $364,000 | $206,000 |
| Short-term debt | $46,000 | $44,000 | $42,000 | $41,000 | $39,000 | $37,000 | $36,000 | $29,000 | $24,000 | $56,000 | $54,000 | $52,000 |
| Total current liabilities | $1.7M | $1.5M | $1.2M | $2.0M | $2.1M | $1.9M | $2.0M | $2.5M | $2.0M | $1.7M | $1.7M | $2.0M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $174,000 | $184,000 | $193,000 | $204,000 | $213,000 | $221,000 | $230,000 | $232,000 | $237,000 | $149,000 | $162,000 | $175,000 |
| Other long-term liabilities | $128,000 | $140,000 | $151,000 | $163,000 | $174,000 | $184,000 | $194,000 | $203,000 | $213,000 | $92,999 | $108,000 | $123,000 |
| Total liabilities | $1.9M | $1.6M | $1.4M | $2.1M | $2.2M | $2.1M | $2.2M | $2.7M | $2.2M | $1.8M | $1.8M | $2.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $346,000 | $339,000 | $335,000 | $330,000 | $328,000 | $322,000 | $322,000 | $322,000 | $321,000 | $320,000 | $318,000 | $311,000 |
| Retained earnings (deficit) | −$259.4M | −$256.8M | −$254.2M | −$251.7M | −$249.0M | −$246.7M | −$243.9M | −$240.8M | −$237.9M | −$234.6M | −$231.5M | −$228.2M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | $0 | — | — | — |
| Minority interest | −$1.3M | −$1.3M | −$1.2M | −$1.2M | −$1.2M | — | — | — | — | — | — | — |
| Total shareholders' equity | $14.5M | $14.5M | $15.1M | $15.2M | $16.6M | $16.1M | $17.9M | $20.0M | $21.8M | $23.6M | $24.6M | $24.3M |
| Key figures | ||||||||||||
| Total debt | $174,000 | $184,000 | $193,000 | $204,000 | $213,000 | $221,000 | $230,000 | $232,000 | $237,000 | $149,000 | $162,000 | $175,000 |
| Net cash (debt) | $13.7M | $13.5M | $14.0M | $15.0M | $15.8M | $15.4M | $17.0M | $19.7M | $20.5M | $23.1M | $23.6M | $23.7M |
| Working capital | $13.2M | $13.2M | $13.8M | $13.9M | $15.4M | $14.9M | $16.7M | $18.9M | $20.7M | $22.5M | $23.6M | $23.3M |
| Tangible book value | $14.5M | $14.5M | $15.1M | $15.2M | $16.6M | $16.1M | $17.9M | $20.0M | $21.8M | $23.6M | $24.6M | $24.3M |
| Book value per share | $0.42 | $0.43 | $0.45 | $0.47 | $0.51 | $0.50 | $0.55 | $0.63 | $0.68 | $0.74 | $0.78 | $0.78 |
| Shares outstanding | 34.2M | 33.6M | 33.2M | 32.5M | 32.5M | 32.2M | 32.2M | 31.9M | 32.1M | 31.9M | 31.4M | 31.1M |
| Current ratio | 8.54 | 9.79 | 12.18 | 8.08 | 8.45 | 8.89 | 9.35 | 8.54 | 11.31 | 14.40 | 15.19 | 12.50 |
| Quick ratio | 7.94 | 9.16 | 11.49 | 7.71 | 7.76 | 8.27 | 8.63 | 8.04 | 10.56 | 13.95 | 14.57 | 11.89 |
| Debt / equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Equity / assets | 96.0% | 97.4% | 99.0% | 94.3% | 94.0% | 94.6% | 94.4% | 92.6% | 95.0% | 97.0% | 97.0% | 95.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed January 12, 2026); data from EODHD.
ANIX financial position
At the end of fiscal 2025 (October 31, 2025), Anixa Biosciences had total assets of $16.1 million (down 25.5% from a year earlier), total liabilities of $2.1 million and shareholders' equity of $15.2 million. It held $15.2 million in cash and short-term investments against $0.2 million of debt, a net cash position of $15.0 million. Its current ratio was 8.08. In the latest quarter (ended July 31, 2026) total assets were $15.1 million and equity $14.5 million.
Related: ANIX income statement, ANIX cash flow statement, ANIX key metrics. See the ANIX stock overview for the latest quote and news.
ANIX balance sheet FAQ
What are Anixa Biosciences's total assets?
Anixa Biosciences reported total assets of $16.1 million at the end of fiscal 2025 (October 31, 2025), compared with $21.6 million a year earlier.
How much debt does Anixa Biosciences have?
Anixa Biosciences had $0.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.01.
How much cash does Anixa Biosciences have?
Anixa Biosciences held $15.2 million in cash and short-term investments at the end of fiscal 2025; with $0.2 million of debt that is net cash of $15.0 million.
What is Anixa Biosciences's book value?
Anixa Biosciences's shareholders' equity (book value) was $15.2 million at the end of fiscal 2025, or $0.47 per share.
What is Anixa Biosciences's current ratio?
Anixa Biosciences had current assets of $15.9 million and current liabilities of $2.0 million, a current ratio of 8.08 (it can cover its short-term obligations).